Clinical trial
Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment
NCT01765075 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2013
- Completion date
- February 28, 2014
- Enrollment
- 25 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
permanent atrial fibrillation